Activated protein C: cost-effective or costly?

Area of Science:

• Critical Care Medicine
• Health Economics
• Pharmacoeconomics

Background:

• Commentary on Dhainaut et al.'s study regarding activated protein C cost-effectiveness in severe sepsis.
• Utilizes "real world" data for economic evaluation.

Discussion:

• Findings align with prior analyses on activated protein C's economic impact.
• Highlights the importance of real-world evidence in critical care.

Key Insights:

• Real-world data supports existing economic evaluations of activated protein C.
• Confirms the necessity of investigating new health technologies in critical care settings.

Outlook:

• Future research should prioritize "real world" studies for critical care innovations.
• Economic evaluations using real-world data are crucial for healthcare decision-making.